Hi Franky
This seems to me another example of confusion created by different interpretations of each clause in the MDR. If your NB is requiring you to add a CAPA reporting requirement in the PMS procedure, then there should be clearly defined criteria, roles/responsibilities and, as appropriate, linkage to other reporting requirements in other procedures. This can create a lot of complexity and confusion in individual procedures.
Would they be open to a single, consolidated procedure for CA/NB reporting requirements, that can include references to appropriate procedures which could trigger a need to report?
I think everyone is trying to figure out how to comply with so many requirements of the MDR. Everyone seems to have a different interpretation!
I wonder if the Notified Bodies are working towards creating common expectations for the industry to avoid so much of non-value added work simply to check a box.
------------------------------
Naveen Agarwal, Ph.D.
Problem Solver | Knowledge Sharer.
Let's Talk Risk!
@https://naveenagarwalphd.substack.com/
------------------------------
Original Message:
Sent: 20-Jun-2023 05:01
From: Franky Dubois
Subject: NC from Notified Body audit
We received during our last external audit following NC from our notified body wrt MDR article 83.4<o:p></o:p>
<o:p> </o:p>
4. If, in the course of the post-market surveillance, a need for preventive or corrective action or both is identified, the manufacturer shall implement the appropriate measures and inform the competent authorities concerned and, where applicable, the notified body. Where a serious incident is identified or a field safety corrective action is implemented, it shall be reported in accordance with Article 87.<o:p></o:p>
<o:p> </o:p>
The NC was states as<o:p></o:p>
Article 83.4 is not addressed in the procedure and/or used templates.<o:p></o:p>
<o:p> </o:p>
So, our NB wants that we formalize in our internal PMS procedure that if we launch a CAPA to investigate anything resulting from PMS, that we should inform the competent authority<o:p></o:p>
<o:p> </o:p>What are competent authorities expecting for this article and. If they want those to be reported, in which format needs this to be done?<o:p></o:p>
CAPAs could be raised for further improvements, without that there was a risk to the patient nor the physician à Are those needed to be reported ?<o:p></o:p>
<o:p> </o:p>
To be clear we are here not talking about vigilance cases where a reporting needs to be done conform Article 87<o:p></o:p>
<o:p> </o:p>
We are bringing class IIa SW products on the market under the MDR<o:p></o:p>
<o:p> </o:p>
------------------------------
Franky Dubois
QA/RA Manager
Gent
Belgium
------------------------------